This inventor holds 5 USPTO granted patents and 6 published patent applications. Top assignee: Kisoji Biotechnology Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Luis Da Cruz: Innovator in Cancer Treatment
Introduction
Luis Da Cruz is a prominent inventor based in Montréal, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of binding agents for cancer treatment. With a total of 5 patents to his name, Da Cruz is recognized for his innovative approaches to targeting tumor cells.
Latest Patents
Among his latest patents, Da Cruz has developed binding agents that specifically target TROP2-expressing tumor cells. These binding agents, including antibodies and antigen binding fragments, are designed to bind to trophoblast cell surface antigen-2 (TROP2). The disclosed technology aims to provide effective treatment options for cancer by utilizing single domain antibodies that specifically bind to amino acid residues of the extracellular domain of TROP2.
Career Highlights
Luis Da Cruz is currently associated with Kisoji Biotechnology Inc., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that can significantly impact cancer therapies.
Collaborations
Da Cruz collaborates with notable colleagues, including Wenyang Hou and Shugang Yao, to enhance the scope and effectiveness of their research initiatives.
Conclusion
Luis Da Cruz stands out as a dedicated inventor in the biotechnology sector, with a focus on developing targeted therapies for cancer treatment. His contributions are paving the way for advancements in medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile